@Deep_Brief438 1 month ago
MRK doesn’t get attention, but it delivers
MRK doesn’t get attention, but it delivers
Merck isn’t something that trends on social media, and yet they keep delivering on pharmaceuticals and cash flows. They, and other healthcare stocks like them, thrive when other sectors stop growing. It’s not an exciting stock, but sometimes execution is important. The question is, do you own boring health stocks, or only look into them when markets get tough?
@Simonwhite 1 month ago
it’s easy to overlook merck when everyone is talking about tech. but their cash flow is hard to ignore.
